-+ 0.00%
-+ 0.00%
-+ 0.00%

IceCure wins China NMPA approval to market ProSense cryoablation system

PUBT·09/10/2026 12:00:21
Listen to the news
IceCure wins China NMPA approval to market ProSense cryoablation system
  • IceCure Medical won China NMPA clearance to market its ProSense cryoablation system as a Class III medical device.
  • The approval allows commercial sales in China under the registered indications for ProSense and its cryoprobes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609100758PR_NEWS_USPR_____IO44937) on September 10, 2026, and is solely responsible for the information contained therein.